Actuate Therapeutics ACTU
NASDAQ ACTU
$0.82 -0.07 (-7.87%)
At close: Oct 2, 2026 · 4:00 PM EDT

Actuate Therapeutics (ACTU) Return on Equity [ROE] (2024 - 2026)

Updated

Actuate Therapeutics (ACTU) posted Return on Equity [ROE] of -466.22% for Q2 2026.

Analysis

Actuate Therapeutics (ACTU) Return on Equity [ROE] (2024 - 2026) Analysis & Trends

For FY2025, Actuate Therapeutics' Return on Equity [ROE] came in at -553.75%.

  • Quarterly Return on Equity [ROE] has run from a low of -913.70% in Q4 2024 to a high of -235.71% in Q4 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 82.09%
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 25.32%
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.21%
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 84.40%
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 21.39%
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 83.75%
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -18.38%
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 4.97%
10 Actuate Therapeutics 19.69 Mn 19.69 Mn - -466.22%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -466.22%
Dec 31, 2025 -235.71%
Sep 30, 2025 -582.43%
Dec 31, 2024 -913.70%
API Access

Actuate Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=ACTU&period=max&api_key=YOUR_API_KEY